Notice Title

Consent to the Distribution of New Medicines

Publication Date
18 Nov 2016

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2016-go6512

Issue Number

104
Title
View PDF
File Type and Size
PDF (22 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Allmercap
Mercaptopurine 20mg/mL
Oral suspension
Link Pharmaceuticals Limited
Nova Laboratories Limited, Leicester, United Kingdom

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Carvedilol
Carvedilol 3.125mg
Tablet
Apotex NZ Limited
Apotex Inc, Toronto, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Carvedilol
Carvedilol 6.25mg
Tablet
Apotex NZ Limited
Apotex Inc, Toronto, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Carvedilol
Carvedilol 12.5mg
Tablet
Apotex NZ Limited
Apotex Inc, Toronto, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Carvedilol
Carvedilol 25mg
Tablet
Apotex NZ Limited
Apotex Inc, Toronto, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Brilinta
Ticagrelor 60mg
Film coated tablet
AstraZeneca Limited
AstraZeneca AB, Sodertalje, Sweden

Product:
Active Ingredients:

Dosage Form:
New Zealand Sponsor:
Manufacturer:

Brimica Genuair
Aclidinium bromide 0.4mg equivalent to aclidinium 0.34mg
Formoterol fumarate dihydrate 0.012mg
Powder for inhalation
A. Menarini New Zealand Pty Limited
Industrias Farmaceuticas Almirall SA (IFA), Barcelona, Spain

Dated this 15th day of November 2016.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).